These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12899958)

  • 1. An efficient HPLC method for the analysis of isomeric purity of technetium-99m-exametazime and identity confirmation using LC-MS.
    Vanderghinste D; Van Eeckhoudt M; Terwinghe C; Mortelmans L; Bormans GM; Verbruggen AM; Vanbilloen HP
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):679-85. PubMed ID: 12899958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
    Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identity confirmation of 99mTc-MAG3, 99mTc-sestamibi and 99mTc-ECD using radio-LC-MS.
    Verduyckt T; Kieffer D; Huyghe D; Cleynhens B; Verbeke K; Verbruggen A; Bormans G
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):669-78. PubMed ID: 12899957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RP-HPLC separation of the diastereomers of technetium-99m labelled tropanes and identity confirmation using radio-LC-MS.
    Vanbilloen HP; Cleynhens BJ; de Groot TJ; Maes A; Bormans GM; Verbruggen AM
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):663-8. PubMed ID: 12899956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilisation of high-activity 99mTc-d,l-HMPAO preparations with cobalt chloride and their biological behaviour.
    Mang'era KO; Vanbilloen HP; Schiepers CW; Verbruggen AM
    Eur J Nucl Med; 1995 Oct; 22(10):1163-72. PubMed ID: 8542901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of antioxidative ability in brain: technetium-99m-meso-HMPAO as an imaging agent for glutathione localization.
    Sasaki T; Toyama H; Oda K; Ogihara-Umeda I; Nishigori H; Senda M
    J Nucl Med; 1996 Oct; 37(10):1698-701. PubMed ID: 8862315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miniaturized Radiochemical Purity Testing for
    Fuente A; Zanca R; Boni R; Cataldi AG; Sollini M; Lazzeri E; Mariani G; Erba PA
    J Nucl Med Technol; 2017 Sep; 45(3):236-240. PubMed ID: 28705928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of glutathione localization in brain using 99mTc meso-HMPAO.
    Sasaki T; Senda M
    J Nucl Med; 1999 Jun; 40(6):1056-60. PubMed ID: 10452324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of radiolytic-produced hydrogen peroxide on the stability of commercial kit (99m) technetium-exametazime preparation.
    Martinez T; Miñana E; Martín-Falquina TC; Fuente T
    J Labelled Comp Radiopharm; 2014 Jan; 57(1):49-52. PubMed ID: 24448745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metabolic alterations on the accumulation of technetium-99m-labeled d,l-HMPAO in slices of rat cerebral cortex.
    Ahn CS; Tow DE; Yu CC; Greene RW
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):324-31. PubMed ID: 8113327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m-meso-HMPAO as a potential agent to image cerebral glutathione content.
    Sasaki T; Senda M
    J Nucl Med; 1997 Jul; 38(7):1125-9. PubMed ID: 9225804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 99mTc aminobisthiolato/monothiolato "3 + 1" mixed ligand complexes: structure-activity relationships and preliminary in vivo validation as brain blood flow imaging agents.
    Pirmettis IC; Papadopoulos MS; Chiotellis E
    J Med Chem; 1997 Aug; 40(16):2539-46. PubMed ID: 9258360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of stabilized 99mTc-D,L-HMPAO stored in vials and syringes.
    Del Carmen Plancha-Mansanet M; Caballero-Calabuig E; Félix-Fontestad J; Reyes-Ojeda MD; Sopena-Novales P; Abreu-Sánchez P; Del Carmen Cano-Terol M; Sopena-Monforte R
    J Nucl Med Technol; 2008 Dec; 36(4):213-6. PubMed ID: 19008289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
    van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
    J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ligand structure on glutathione-mediated decomposition of propylene amine oxime derivatives.
    Roth CA; Hoffman TJ; Corlija M; Volkert WA; Holmes RA
    Int J Rad Appl Instrum B; 1992 Oct; 19(7):783-90. PubMed ID: 1399700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of technetium-99m-d,1-HMPAO to radiolysis in aqueous solutions.
    Tubergen K; Corlija M; Volkert WA; Holmes RA
    J Nucl Med; 1991 Jan; 32(1):111-5. PubMed ID: 1988613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radio-LC-MS for the characterization of 99mTc-labeled bioconjugates.
    Liu S; Ziegler MC; Edwards DS
    Bioconjug Chem; 2000; 11(1):113-7. PubMed ID: 10639093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven-hour stabilization of 99Tcm-exametazime (HMPAO) for cerebral perfusion.
    Solanki C; Wraight EP; Barber RW; Sampson CB
    Nucl Med Commun; 1998 Jun; 19(6):567-72. PubMed ID: 10234661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of Tc-D,D-HMPAO and Tc-L,L-HMPAO and their comparison of chemical and biological properties.
    Ding HJ; Huang YF; Tzeng CC; Wei LM; Yeh SJ
    Bioorg Med Chem Lett; 1999 Nov; 9(22):3199-202. PubMed ID: 10576687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.